icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
Back grey_arrow_rt.gif
 
 
 
Real-World Persistency of Bulevirtide Therapy in Chronic Hepatitis D Patients in Germany: A Retrospective Observational Analysis
 
 
 
AASLD 2025 Nov 7-11 Wash DC
 
Dirk Nierhoff1, Marianna Schwenken2, Monika Weischenberg3, Markus Cornberg4, Mehtap Guendogdu5, Kyung min Kwon6, Amanda Singer7, Michael Mertens8, Jörg Petersen9 1University Hospital Cologne, Department of Gastroenterology and Hepatology, Germany; 2-3Gilead Sciences GmbH, Munich, Germany; 4Hannover Medical School, Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover, Germany; 5Gilead Sciences GmbH, Munich, Germany; 6-7Gilead Sciences, Inc., Foster City, USA; 8Gilead Sciences Europe Ltd., Stockley Park, UK; 9IFI Institute for Interdisciplinary Medicine, Hamburg, Germany

1112251

1112252

1112253

1112254

1112255

1112256